Literature DB >> 11780370

Changes in intestinal microflora in patients with chronic severe hepatitis.

L Li1, Z Wu, W Ma, Y Yu, Y Chen.   

Abstract

OBJECTIVE: To investigate changes in intestinal microflora in patients with chronic severe hepatitis (CSH), and their role in this life-threatening disease.
METHODS: We classified nineteen patients with chronic severe hepatitis as the CSH group, thirty patients with chronic hepatitis (CH) as the CH group and thirty-one healthy volunteer as the control group. Fecal flora from all subjects were analyzed. Concentrations of plasma endotoxin, serum cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) and liver function were assessed.
RESULTS: The number of fecal bifidobacterium (P < 0.001, P < 0.05 respectively), as well as bacteroidaceae (P < 0.001, P < 0.01 respectively) were significantly deceased in patients with chronic severe hepatitis compared with the CH and control groups, while the number of enterobacteriaceae (P < 0.001, P < 0.05 respectively) and yeasts (P < 0.01, P < 0.05 respectively) were significantly increased. Levels of plasma endotoxin, serum TNF-alpha, IL-1 beta and total bilirubin (TBiL) were significantly increased in the CSH group. The concentration of endotoxin positively correlated with levels of both TNF-alpha, IL-1 beta and TBiL (P < 0.001, respectively). Levels of plasma endotoxin were positively correlated with the number of fecal enterobacteriaceae and negatively correlated with bifidobacterium (P < 0.05, P < 0.001, respectively).
CONCLUSION: Intestinal flora in patients with chronic severe hepatitis were severely disturbed and gut microbiological colonization resistance was impaired. Changes in intestinal flora may have a pivotal role in both the elevation of plasma endotoxin and further hepatic lesions resulting in liver failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11780370

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  10 in total

1.  Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease.

Authors:  Min Xu; Baohong Wang; Yiqi Fu; Yanfei Chen; Fengling Yang; Haifeng Lu; Yunbo Chen; Jiali Xu; Lanjuan Li
Journal:  Microb Ecol       Date:  2011-08-04       Impact factor: 4.552

2.  Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats.

Authors:  Lu-Wen Wang; Li-Kun Wang; Hui Chen; Cheng Fan; Xun Li; Can-Ming He; Zuo-Jiong Gong
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 3.  Clostridium difficile infection in patients with liver disease: a review.

Authors:  A Trifan; O Stoica; C Stanciu; C Cojocariu; A-M Singeap; I Girleanu; E Miftode
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-10-06       Impact factor: 3.267

4.  Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients.

Authors:  Xiaoning Wang; Guoxiang Xie; Xiaoyan Wang; Mingmei Zhou; Huan Yu; Yan Lin; Guangli Du; Guoan Luo; Ping Liu
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-18       Impact factor: 2.629

5.  Baicalein reduces the occurrence of cirrhotic endotoxemia by reducing intestinal mucosal apoptosis.

Authors:  Yi Liu; Feng Ye; Wen-Jing Zou; Ye Sun; Rui Wang; Ping-Ping Han; Zhe Zhang; Xue-Liang Yang; Xiaojin Liu
Journal:  BMC Complement Altern Med       Date:  2015-05-29       Impact factor: 3.659

6.  The Association of Chronic Hepatitis C with Respiratory Microbiota Disturbance on the Basis of Decreased Haemophilus Spp. Colonization.

Authors:  Urszula Kosikowska; Anna Biernasiuk; Izabela Korona-Głowniak; Sławomir Kiciak; Krzysztof Tomasiewicz; Anna Malm
Journal:  Med Sci Monit       Date:  2016-02-25

7.  Intestinal flora imbalance promotes alcohol-induced liver fibrosis by the TGFβ/smad signaling pathway in mice.

Authors:  Dong Zhang; Xiuxian Hao; Lili Xu; Jing Cui; Li Xue; Zibin Tian
Journal:  Oncol Lett       Date:  2017-08-17       Impact factor: 2.967

8.  Modulations of Histone Deacetylase 2 Offer a Protective Effect through the Mitochondrial Apoptosis Pathway in Acute Liver Failure.

Authors:  Yao Wang; Fan Yang; Fang-Zhou Jiao; Qian Chen; Wen-Bin Zhang; Lu-Wen Wang; Zuo-Jiong Gong
Journal:  Oxid Med Cell Longev       Date:  2019-04-28       Impact factor: 6.543

9.  Dynamic changes of lipopolysaccharide levels in different phases of acute on chronic hepatitis B liver failure.

Authors:  Calvin Pan; Yurong Gu; Wei Zhang; Yubao Zheng; Liang Peng; Hong Deng; Youming Chen; Lubiao Chen; Sui Chen; Min Zhang; Zhiliang Gao
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

10.  Serum Immunoglobulin A (IgA) Level Is a Potential Biomarker Indicating Cirrhosis during Chronic Hepatitis B Infection.

Authors:  Sha Lin; QinQin Sun; WeiLin Mao; Yu Chen
Journal:  Gastroenterol Res Pract       Date:  2016-03-30       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.